BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le KTT, Chu X, Jaeger M, Plantinga JA, Matzaraki V, Withoff S, Joosten LAB, Netea MG, Wijmenga C, Li Y, Moser J, Kumar V. Leukocyte-Released Mediators in Response to Both Bacterial and Fungal Infections Trigger IFN Pathways, Independent of IL-1 and TNF-α, in Endothelial Cells. Front Immunol 2019;10:2508. [PMID: 31708927 DOI: 10.3389/fimmu.2019.02508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Aguilar-Briseño JA, Moser J, Rodenhuis-Zybert IA. Understanding immunopathology of severe dengue: lessons learnt from sepsis. Curr Opin Virol 2020;43:41-9. [PMID: 32896675 DOI: 10.1016/j.coviro.2020.07.010] [Reference Citation Analysis]
2 Tu F, Wang X, Zhang X, Ha T, Wang Y, Fan M, Yang K, Gill PS, Ozment TR, Dai Y, Liu L, Williams DL, Li C. Novel Role of Endothelial Derived Exosomal HSPA12B in Regulating Macrophage Inflammatory Responses in Polymicrobial Sepsis. Front Immunol 2020;11:825. [PMID: 32457753 DOI: 10.3389/fimmu.2020.00825] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 da Silva PR, do Espírito Santo RF, Melo CO, Pachú Cavalcante FE, Costa TB, Barbosa YV, E Silva YMSM, de Sousa NF, Villarreal CF, de Moura RO, Dos Santos VL. The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases. Pharmaceutics 2022;14:188. [PMID: 35057082 DOI: 10.3390/pharmaceutics14010188] [Reference Citation Analysis]
4 Brown JL, Townsend E, Short RD, Williams C, Woodall C, Nile CJ, Ramage G. Assessing the inflammatory response to in vitro polymicrobial wound biofilms in a skin epidermis model. NPJ Biofilms Microbiomes 2022;8:19. [PMID: 35393409 DOI: 10.1038/s41522-022-00286-z] [Reference Citation Analysis]
5 Luxen M, van Meurs M, Molema G. Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design. Front Immunol 2022;13:867625. [DOI: 10.3389/fimmu.2022.867625] [Reference Citation Analysis]